Stay updated with breaking news from Eric Biondi. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Explore the challenges and hopes surrounding breakthrough RSV vaccines, as infant immunization, elderly vaccination, and supply chain hurdles shape the uneven uptake of these game-changing tools against respiratory syncytial virus.
Jackyenjoyphotography/Getty Images(NEW YORK) -- For years, respiratory syncytial virus (RSV) has been the most common reason infants are hospitalized in the U.S. and has hospitalized thousands of elderly people every year. After decades of trying to develop a vaccine, they became available ahead of this season for the first time for adults aged 60 and older and for pregnant people between 32 weeks' and 36 weeks' gestation. Additionally, for the first time ever, an injectable monoclonal antibody shot to protect babies aged 8 months and younger and certain high-risk children under 24 months also...
Despite a recent rise in COVID-19 hospitalizations and emergence of a new virus variant, some clinicians remain optimistic that this fall and winter won't become another 'tripledemic' season.
For working parents of young children, it seems the rest of the world has moved on from the pandemic. But unending illness and child care disruptions have upended these families'
Forty-seven. That’s how many days of child care Kathryn Anne Edwards’ 3-year-old son has missed in the past year. RSV, COVID-19 and two bouts of the dreaded preschool scourge of hand, foot and mouth disease struck one after another. The illnesses were so disruptive that the labor economist quit her full-time job at the Rand ...